BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kawada K, Hasegawa S, Murakami T, Itatani Y, Hosogi H, Sonoshita M, Kitamura T, Fujishita T, Iwamoto M, Matsumoto T. Molecular mechanisms of liver metastasis. Int J Clin Oncol. 2011;16:464-472. [PMID: 21847533 DOI: 10.1007/s10147-011-0307-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhao JX, Liu LR, Yang XY, Liu F, Zhang ZG. Serum CA19-9 as a marker of circulating tumor cells in first reflux blood of colorectal cancer patients. Oncotarget 2017;8:67918-32. [PMID: 28978084 DOI: 10.18632/oncotarget.18912] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
2 Cong N, Li Z, Shao W, Li J, Yu S. Activation of ETA Receptor by Endothelin-1 Induces Hepatocellular Carcinoma Cell Migration and Invasion via ERK1/2 and AKT Signaling Pathways. J Membr Biol 2016;249:119-28. [PMID: 26501871 DOI: 10.1007/s00232-015-9854-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
3 Hou H, Ge C, Sun H, Li H, Li J, Tian H. Tunicamycin inhibits cell proliferation and migration in hepatocellular carcinoma through suppression of CD44s and the ERK1/2 pathway. Cancer Sci 2018;109:1088-100. [PMID: 29377347 DOI: 10.1111/cas.13518] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
4 Yi Z, Li Y, Liu D, Liu J, Li H. Extracellular HSP70/HSP70-PCs regulate hepatocarcinoma cell migration and invasion via RhoA. Oncol Lett 2017;13:1095-100. [PMID: 28454219 DOI: 10.3892/ol.2016.5551] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
5 Cloyd JM, Abdel-Misih S, Hays J, Dillhoff ME, Pawlik TM, Schmidt C. Impact of Synchronous Liver Resection on the Perioperative Outcomes of Patients Undergoing CRS-HIPEC. J Gastrointest Surg 2018;22:1576-84. [PMID: 29713875 DOI: 10.1007/s11605-018-3784-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
6 Conotte R, Colet J. A metabonomic evaluation of the monocrotaline-induced sinusoidal obstruction syndrome (SOS) in rats. Toxicology and Applied Pharmacology 2014;276:147-56. [DOI: 10.1016/j.taap.2014.02.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
7 Oliveira RC, Alexandrino H, Cipriano MA, Tralhão JG. Liver Metastases and Histological Growth Patterns: Biological Behavior and Potential Clinical Implications-Another Path to Individualized Medicine? J Oncol 2019;2019:6280347. [PMID: 30930945 DOI: 10.1155/2019/6280347] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
8 Canavese M, Ngo DT, Maddern GJ, Hardingham JE, Price TJ, Hauben E. Biology and therapeutic implications of VEGF-A splice isoforms and single-nucleotide polymorphisms in colorectal cancer. Int J Cancer 2017;140:2183-91. [PMID: 27943279 DOI: 10.1002/ijc.30567] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
9 Huang WH, Zhou MW, Zhu YF, Xiang JB, Li ZY, Wang ZH, Zhou YM, Yang Y, Chen ZY, Gu XD. The Role Of Hepatic Stellate Cells In Promoting Liver Metastasis Of Colorectal Carcinoma. Onco Targets Ther 2019;12:7573-80. [PMID: 31571908 DOI: 10.2147/OTT.S214409] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Galindo-Pumariño C, Collado M, Herrera M, Peña C. Tumor Microenvironment in Metastatic Colorectal Cancer: The Arbitrator in Patients' Outcome. Cancers (Basel) 2021;13:1130. [PMID: 33800796 DOI: 10.3390/cancers13051130] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Fahrner M, Bronsert P, Fichtner-Feigl S, Jud A, Schilling O. Proteome biology of primary colorectal carcinoma and corresponding liver metastases. Neoplasia 2021;23:1240-51. [PMID: 34768110 DOI: 10.1016/j.neo.2021.10.005] [Reference Citation Analysis]
12 Herszényi L, Barabás L, Hritz I, István G, Tulassay Z. Impact of proteolytic enzymes in colorectal cancer development and progression. World J Gastroenterol 2014; 20(37): 13246-13257 [PMID: 25309062 DOI: 10.3748/wjg.v20.i37.13246] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
13 Hagness M, Foss A, Egge TS, Dueland S. Patterns of recurrence after liver transplantation for nonresectable liver metastases from colorectal cancer. Ann Surg Oncol. 2014;21:1323-1329. [PMID: 24370906 DOI: 10.1245/s10434-013-3449-9] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 5.4] [Reference Citation Analysis]
14 Bai M, Chen X, Ba YI. CXCL10/CXCR3 overexpression as a biomarker of poor prognosis in patients with stage II colorectal cancer. Mol Clin Oncol 2016;4:23-30. [PMID: 26870351 DOI: 10.3892/mco.2015.665] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]